In Vitro Antibody Discovery Intern, Master's and PhD Students jobs in United States
cer-icon
Apply on Employer Site
company-logo

Alexion Pharmaceuticals, Inc. · 2 days ago

In Vitro Antibody Discovery Intern, Master's and PhD Students

Alexion Pharmaceuticals, Inc. is looking for Master’s and PhD level students for a 12-week internship role. The intern will perform wet lab experiments and analyze experimental results, contributing to the discovery platforms in biologics engineering.

BiotechnologyHealth CareMedicalTherapeutics
check
Comp. & Benefits
badNo H1Bnote

Responsibilities

Perform wet lab experiments (phage and yeast culture, ELISA, flow cytometry, etc.)
Analyze and organize experimental results using Prism, Microsoft Excel, PowerPoint, Word, etc. for oral and poster presentations
Accurate and precise data capture using Signals ELN and Genedata Biologics

Qualification

Wet lab skillsPrismCell cultureELISAFlow cytometryMicrosoft OfficeAutomation familiarityHigh-throughput setup

Required

Master's and PhD level students majoring in Biochemistry, Biomedical Engineering, Biotechnology, Molecular Biology, Cell Biology or a related discipline. Candidates must have an expected graduation date after August 2026
Basic wet lab skills such as pipetting and reagent preparation are required
Proficiency in Prism and Microsoft Office tools, such as Outlook, Excel, PowerPoint, and Word are required
Ability to report onsite to Gaithersburg, MD 3-5 days per week. This role will not provide relocation assistance
US Work Authorization is required at time of application
This role will not be providing OPT support

Preferred

Previous hands-on experience of performing cell culture, ELISA, BLI, and flow cytometry are a plus
Familiarity with automation and high-throughput experiment set up is highly preferred

Company

Alexion Pharmaceuticals, Inc.

company-logo
Alexion, AstraZeneca Rare Disease is focused on pioneering new possibilities for the rare disease community.

Funding

Current Stage
Public Company
Total Funding
$5.8M
2020-12-12Acquired
1999-02-12Post Ipo Equity· $5.8M
1996-02-29IPO

Leadership Team

leader-logo
Frederic Chereau
SVP, Strategy and Business Development
linkedin
leader-logo
Imran Shakur
Director, IRT and Technology Lead
linkedin
Company data provided by crunchbase